ICSG Corp. Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • ICSG Corp.'s estimated annual revenue is currently $540k per year.(i)
  • ICSG Corp.'s estimated revenue per employee is $135,000

Employee Data

  • ICSG Corp. has 4 Employees.(i)
  • ICSG Corp. grew their employee count by -85% last year.

ICSG Corp.'s People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.9M323%N/AN/A
#2
$13.4M5510%N/AN/A
#3
$25.4M9411%N/AN/A
#4
$78.4M26416%N/AN/A
#5
$9.3M4310%N/AN/A
#6
$51.1M17224%N/AN/A
#7
$65M2190%N/AN/A
#8
$44.8M1519%N/AN/A
#9
$6.7M31-11%N/AN/A
#10
$9.5M447%N/AN/A
Add Company

What Is ICSG Corp.?

PRECISE FULL SERVICE LABORATORY COVID-19 testing is now available. GOT FLU? - Our Office now offers a Respiratory Pathogen Panel to keep you Healthy. The RPP panel employs PCR or (Polymerase Chain Reaction) to amplify specific nucleic acid sequences with the pathogens genetic make-up. • Our limits of detection are far superior to conventional screen methods as we employ PCR technology, allowing us to amplify small quantities of nucleic acid into detectable levels. • Typical symptoms can be dry or productive cough, runny nose, lethargy, abnormal sputum, fever, body aches. • They may be asymptomatic and growing the infection. Their bodies keep the disease in check, until It can’t anymore and they become sick. RESPIRATORY PATHOGEN PANEL The RPP Test can pinpoint the Influenza virus and a number of other respiratory viruses and/or Pneumonia bacteria so your physician can treat it swiftly and accurately; therefore, it could reduce its severity and illness timeframe. Treatment protocols for bacterial respiratory pathogens are vastly dierent than those for viral pathogens so knowing the pathogen is key to proper and eective treatment. Molecular testing is far superior to the screen testing traditionally used in physicians’

keywords:N/A

N/A

Total Funding

4

Number of Employees

$540k

Revenue (est)

-85%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.1M4-56%$30M
#2
N/A4N/AN/A
#3
$0.4M40%N/A
#4
$0.3M4-20%N/A
#5
$0.3M4-43%N/A